HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication

Springer Seminars in Immunopathology

Volumn 18, Issue 3, 1997, Pages 341-354

  Jassoy, Christian ^a   Walker, Bruce D ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS REPLICATION;

ANIMALS; HIV INFECTIONS; HIV-1; HUMANS; T-LYMPHOCYTES, CYTOTOXIC; VIRUS REPLICATION;

EID: 0031058734     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00813502     Document Type: Article

References (104)

1. Aebischer T, Moskophidis D, Rohrer UH, Zinkernagel RM, Hengartner H (1991) In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. Proc Natl Acad Sci USA 88:11047
2. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955
3. Baier M, Werner A, Bannert N, Metzner K, Kurth R (1995) HIV suppression by interleukin-16 (letter; comment). Nature 378:563
4. Banks TA, Rouse BT (1992) Herpes viruses - immune escape artists? (Review). Clin Infect Dis 14:933
5. + T cell supressor activities. J Immunol 156:4476
6. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De-Carli M, Fiaccadori F, Ferrari C (1994) Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407
7. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103
8. Borrow P, Evans CF, Oldstone MB (1995) Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol 69:1059
9. Brander C, Walker BD (1995) The HLA-class I restricted CTL response in HIV-1 infection: identification of optimal epitopes. In: Koerber BTM, Brander C, Walker BD (eds) Theoretical biology and biophysics. HIV molecular immunology database. Los Alamos National Laboratory, Los Alamos
10. + T cells. Evidence for a soluble inhibitor. J Immunol 144:2961
11. Byrne JA, Oldstone MB (1984) Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol 51:682
12. Cao Y, Qin L, Zhang L, Safrit S, Ho DD (1995) Virologie and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection (see comments). N Engl J Med. 332:201
13. Carmichael A, Jin X, Sissons P, Borysiewicz L (1993) Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 177:249
14. Chen C-H, Weinhold K, Bartlett JA, Bolognesi DP, Greenberg ML (1993) CD8 T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retroviruses 9:1079
15. Chen ZW, Shen L, Miller MD, Ghim SH, Hughes AL, Letvin NL (1992) Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag. J Immunol 149:4060
16. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ cells. Science 270:1811
17. Couillin I, Culmann-Penciolelli B, Gomard E, Choppin J, Levy J-P, Guillet J-G, Saragosti S (1994) Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J Exp Med 180:1129
18. Devergne O, Peuchmaur M, Crevon MC, Trapani JA, Maillot MC, Galanaud P, Emilie D (1991) Activation of cytotoxic cells in hyperplastic lymph nodes from HIV-infected patients AIDS 5:1071
19. Falk K, Rotzschke O, Deres K, Metzger J, Jung G, Rammensee HG (1991) Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J Exp Med 174:425
20. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290
21. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor (see comments). Science 272:872
22. + lymphocyte activity. J Infect Dis 172:329
23. Franker SS, Wenig BM, Burke AP, Mannan P, Thompson LDR, Abbondanzo SL, Nelson AM, Pope M, Steinman RM (1996) Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272:115
24. Gotch FM, Nixon DF, Alp N, McMichael AJ, Borysiewicz LK (1990) High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol 2:707
25. Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, Adle-Biassette H, Wingertsmann L, Durigon M, Hurtrel B, Chiodi F, Bell J, Lantos P (1996) Neuropathology of early HIV-1 infection. Brain Pathol 6:1
26. Hadida F, Parrot A, Kieny MP, Sadat SB, Mayaud C, Debre P, Autran B (1992) Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. J Clin Invest 89:53
27. Harrer T, Jassoy C, Harrer E, Johnson RP, Walker BD (1993) Induction of HIV-1 replication in a chronically infected T-cell line by cytotoxic T lymphocytes. J Acquir Immune Defic Syndr 6:865
28. Harrer T, Harrer E, Kalams S, Barbosa P, Trocha A, Johnson R, Elbeik T, Feinberg M, Buchbinder S, Walker B (1996) Cytotoxic T lymphocytes in asymptomatic long-term non-progressing HIV-1 infection: breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol 156:2616
29. Harrer T, Harrer E, Kalams SA, Trocha A, Johnson RP, Elbeik T, Feinberg M, Cao H, Ho DD, Buchbinder S, Walker B (1996) Strong cytotoxic T cells and weak neutralizing antibodies in a subset of persons with long-term non-progressing HIV-1 infection. AIDS Res Hum Retro 12:585
30. Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 91:7311
31. Hermiston TW, Tripp RA, Sparer T, Gooding LR, Wold WS (1993) Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J Virol 67:5289
32. Heslop HE, Ng CY, Li C, Smith CA, Loftin SK, Krance RA, Brenner MK, Rooney CM (1996) Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med 2:551
33. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411
34. Howcroft TK, Strebel K, Martin MA, Singer DS (1993) Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260:1320
35. Jassoy C, Walker B (1996) Cytotoxic T lymphocytes and their cytokines in human immunodeficiency virus infection. Crit Rev Oncogen (in press)
36. Jassoy C, Johnson RP, Navia BA, Worth J, Walker BD (1992) Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J Immunol 149:3113
37. Jassoy C, Harrer T, Rosenthal T, Navia BA, Worth J, Johnson RP, Walker BD (1993) Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens. J Virol 67:2844
38. Jassoy C, Heinkelein M, Klinker H, Walker BD (1994) HIV type 1-specific cytotoxic T lymphocytes stimulate HLA class I and intercellular adhesion molecule type 1 expression and increase beta 2-microglobulin levels in vitro. AIDS Res Hum Retroviruses 10:1685
39. Johnson R, Walker B (1994) Cytotoxic T lymphocytes in HIV infection: Responses to structural proteins. Curr Top Microbiol Immunol 189:35-62
40. Jowett JB, Planelles V, Poon B, Shah NP, Chen ML, Chen IS (1995) The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol 69:6304
41. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31
42. Kagi D, Ledermann B, Burki K, Zinkernagel RM, Hengartner H (1995) Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance (Review). Immunol Rev 146:95
43. Kagi D, Seiler P, Pavlovic J, Ledermann B, Burki K, Zinkernagel RM, Hengartner H (1995) The roles of perform- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 25:3256
44. Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, DAquila RT, Kumick JT, Walker BD (1994) Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med 179:1261
45. 8+ lymphocytes. J Immunol 140:2237
46. 8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J Immunol 65:3399
47. Kewalramani VN, Park CS, Gallombardo PA, Emerman M (1996) Protein stability influences human immunodeficiency virus type 2 Vpr virion incorporation and cell cycle effect. Virology 218:326
48. Klein MR, van Baalen C, Holwerda A, Kerkhof-Garde S, Bende R, Keet I, Eeftink-Schattenkerk J-K, Osterhaus A, Schuitemaker H, Miedema F (1995) Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptornatics. J Exp Med 181:1356
49. Klenerman P, Rowland-Jones S, McAdam S, Edwards J, Daenke S, Lalloo D, Koppe B, Rosenberg W, Boyd D, Edwards A, Giangrande P, Phillips R, McMichael A (1994) Cytotoxic T cell activity antagonized by naturally occurring HIV-1 gag variants. Nature 369:403
50. Koup RA, Pikora CA, Luzuriaga K, Brettler DB, Day ES, Mazzara GP, Sullivan JL (1991) Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell pupulations with p17 and p24 specificities. J Exp Med 174:1593
51. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650
52. Lamhamedi-Cherradi S, Culmann-Penciolelli B, Guy B, Ly TD, Goujard C, Guillet JG, Gomard E (1995) Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection. AIDS 9:421
53. + T cells. Immunol Today 17:217
54. Lowin B, Hahne M, Mattmann C, Tschopp J (1994) Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370:650
55. + cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 87:1462
56. Mackewicz CE, Yang LC, Lifson JD, Levy JA (1994) Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet 344:1671
57. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 92:2308
58. Martz E, Howell D (1989) CTL: virus control first and cytolytic cells second? Immunol Today 10:79
59. + cytotoxic T-cell responses during chronic viral infection. J Virol 68:8056
60. McMichael AJ, Walker BD (1994) Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 8 [Suppl 1]:S155
61. McMichael AJ, Gotch FM, Cullen P, Askonas BA, Webster RG (1981) The human cytotoxic T cell response to influenza A vaccination. Clin Exp Immunol 43:276
62. Meier UC, Klenerman P, Griffin P, James W, Koppe B, Larder B, McMichael A, Phillips R (1995) Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science 270:1360
63. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA (1996) Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167
64. Meyerhans A, Dadaglio G, Vartanian J-P, Langlade-Demoyen P, Frank R, Asjö B, Plata F, Wain-Hobson S (1991) In vivo persistence of an HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity. Eur J Immunol 21:2637
65. Miedema F, Meyaard L, Koot M, et al (1994) Changing virus-host interactions in the course of HIV-1 infection. Immunol Rev 140:35
66. Moskophidis D, Zinkernagel RM (1995) Immunobiology of CTL escape mutants of LCMV. J Virol 69:2187
67. Moss PA, Rowland-Jones SL, Frodsham PM, McAdam S, Giangrande P, McMichael AJ, Bell JI (1995) Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci USA 92:5773
68. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M (1994) Functional role of type I and type II interferons in antiviral defense. Science 264:1918
69. Nietfield W, Bauer M, Fevrier M, Maier R, Holzwarth B, Frank R, Maier B, Riviere Y, Meyerhans A (1995) Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope. J Immunol 154:2189
70. Nowak M, May RM, Phillips RE, Rowland-Jones S, Lalloo DG, McAdam S, Klenerman P, Koeppe B, Sigmund K, Bangham CRM, McMichael AJ (1995) Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606
71. + lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 334:426
72. Pantaleo G, Graziosi C, Fauci AS (1993) New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327
73. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 370:463
74. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582
75. Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel RM (1990) Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629
76. Plata F, Autran B, Martins LP, Wain HS, Raphael M, Mayaud C, Denis M, Guillon JM, Debre P (1987) AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328:348
77. Price P, Johnson RP, Scadden DT, Jassoy C, Rosenthal T, Kalams S, Walker BD (1995) Cytotoxic CDS+ lymphocytes reactive with human immunodeficiency virus-1 produce granulocyte/macrophage colony-stimulating factor and variable amounts of interleukins 2, 3, and 4 following stimulation with the cognate epitope. Clin Immunol Immunopathol 74:100
78. Quinnan GVJ, Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, Santos GW Saral R, Bums WH (1982) Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 307:7
79. + lymphocyte response in lymph nodes from patients with HIV infection. In: Racz P, Letvin N, Gluckman J (eds) Cytotoxic T cells in HIV and other retroviral infections. Karger, Basel, pp 162-173
80. Ramsay A, Ruby J, Ramshaw I (1993) A case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 14:155
81. Reimann K, Tenner-Racz K, Racz P, Montefiori D, Yasutomi Y, Lin W, Ransil B, Letvin N (1994) Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Virol 68:2362
82. Ringler D, Hancock W, King N, Letvin N, Daniel M, Derosiers R, Murphy G (1987) Immunophenotypic characterization of the cutaneous exanthem of SIV-infected rhesus monkeys. Am J Pathol 126:199
83. Riviere Y, Robertson MN, Buseyne F (1994) Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes (Review). Curr Top Microbiol Immunol 189:65
84. + lymphocytes. Proc Natl Acad Sci USA 91:1104
85. + long-term survivor. AIDS Res Hum Retroviruses 10:1703
86. 85a. Sethi K, Naeher H, Stroehmann I (1988) Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. Nature 335:178-181
87. Sethi KK, Omata Y, Schneweis KE (1983) Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes. J Gen Virol 64:443
88. + cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein. Proc Natl Acad Sci 88:10277
89. + lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients. Am J Pathol 142:1750
90. Tsubota H, Lord CI, Watkins DI, Morimoto C, Letvin NL (1989) A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med 169:1421
91. Von Herrath M, Oldstone MB, Fox HS (1995) Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J Immunol 154:5582
92. Von Herrath MG, Yokoyama M, Dockter J, Oldstone MB, Whitton JL (1996) CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. J Virol 70:1072
93. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT (1987) HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345
94. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563
95. + cells involves a noncytotoxic mechanism. J Virol 65:5921
96. + T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol 137:420
97. Walter E, Greenberg P, Gilbert M, Finch R, Watanabe K, Thomas E, Riddell S (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl Med 333:1038
98. Yamamoto H, Ringler DJ, Miller MD, Yasutomi Y, Hasunuma T, Lelvin NL (1992) Simian immunodeficiency virus-specific cytotoxic T lymphocytes are present in the AIDS-associated skin rash in rhesus monkeys. J Immunol 149:728
99. Yang OO, Johnson RP, Kalams SA, Trocha A, Walker BD (1996) HIV-1-specific cytotoxic T lymphocytes inhibit HIV-1 replication by specific and non-specific mechanisms. In: Abstracts of the XI International AIDS Conference. Vancouver, 1996
100. Yang OO, Kalams SA, Rosenzweig M, Trocha A, Jones N, Koziel M, Walker BD, Johnson RP (1996) Efficient lysis of HIV-1 infected cells by cytotoxic T lymphocytes. J Virol 70:5799
101. Yap KL, Ada GL, McKenzie IF (1978) Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273:238
102. + T lymphocytes. Cell 77:525
103. Zinkernagel RM, Althage A (1977) Antiviral protection by virus-immune cytotoxic T cells. Infected target cells are lysed before infectious virus progeny is assembled. J Exp Med 145:644
104. Zinkernagel RM, Hengartner H (1994) T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS (Review). Immunol Today 15:262